Houston, TX · Founded 2015 · Privately Held (backing)
Developer of a biomedical engineering technology designed to improve the quality and length of life for dialysis patients. VenoStent is based in Houston, TX and was founded in 2015. It has raised $22.8 million across 2 recorded rounds; the latest was a $10 million early-stage round in Apr 2026.
Last price · $/share
—
Implied valuation
—
Total raised
$22.8M
Last round
Early Stage VC
Apr 2026
Team — not yet on record
No current team members for VenoStent are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of VenoStent with a free account
·The complete investor list: 30 names
·Watch VenoStent: the Monday email on marks, rounds and moves
